Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 6 completed trials

    Completion Rate
    100%(6/6)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2
    3
    50%
    Phase 3
    3
    50%

    Phase Distribution

    0

    Early Stage

    3

    Mid Stage

    3

    Late Stage

    Phase Distribution6 total trials
    Phase 2Efficacy & side effects
    3(50.0%)
    Phase 3Large-scale testing
    3(50.0%)

    Highest Phase Reached

    Phase 3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    6 of 6 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    6

    all time

    Status Distribution
    Completed(6)

    Detailed Status

    Completed6

    Development Timeline

    Analytics

    Development Status

    Total Trials
    6
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 3

    Trials by Phase

    Phase 23 (50.0%)
    Phase 33 (50.0%)

    Trials by Status

    completed6100%

    Recent Activity

    0 active trials
    Showing 5 of 6
    completedphase_2

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

    NCT00407225
    completedphase_3

    Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

    NCT00406341
    completedphase_2

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

    NCT00406497
    completedphase_3

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

    NCT00406887
    completedphase_3

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

    NCT00407056
    View all 6 trials

    Clinical Trials (6)

    Showing 6 of 6 trials
    NCT00407225Phase 2

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

    Completed
    NCT00406341Phase 3

    Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

    Completed
    NCT00406497Phase 2

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

    Completed
    NCT00406887Phase 3

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

    Completed
    NCT00407056Phase 3

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

    Completed
    NCT00405496Phase 2

    Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

    Completed

    All 6 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    6